1. Home
  2. ACCO vs VERV Comparison

ACCO vs VERV Comparison

Compare ACCO & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACCO
  • VERV
  • Stock Information
  • Founded
  • ACCO 1893
  • VERV 2018
  • Country
  • ACCO United States
  • VERV United States
  • Employees
  • ACCO N/A
  • VERV N/A
  • Industry
  • ACCO Publishing
  • VERV Medicinal Chemicals and Botanical Products
  • Sector
  • ACCO Consumer Discretionary
  • VERV Health Care
  • Exchange
  • ACCO Nasdaq
  • VERV Nasdaq
  • Market Cap
  • ACCO 487.6M
  • VERV 475.0M
  • IPO Year
  • ACCO N/A
  • VERV 2021
  • Fundamental
  • Price
  • ACCO $5.20
  • VERV $6.14
  • Analyst Decision
  • ACCO Buy
  • VERV Strong Buy
  • Analyst Count
  • ACCO 1
  • VERV 4
  • Target Price
  • ACCO $7.50
  • VERV $25.75
  • AVG Volume (30 Days)
  • ACCO 620.3K
  • VERV 1.5M
  • Earning Date
  • ACCO 02-20-2025
  • VERV 02-25-2025
  • Dividend Yield
  • ACCO 5.77%
  • VERV N/A
  • EPS Growth
  • ACCO N/A
  • VERV N/A
  • EPS
  • ACCO N/A
  • VERV N/A
  • Revenue
  • ACCO $1,706,700,000.00
  • VERV $24,396,000.00
  • Revenue This Year
  • ACCO N/A
  • VERV $97.47
  • Revenue Next Year
  • ACCO $0.70
  • VERV N/A
  • P/E Ratio
  • ACCO N/A
  • VERV N/A
  • Revenue Growth
  • ACCO N/A
  • VERV 219.91
  • 52 Week Low
  • ACCO $4.37
  • VERV $4.31
  • 52 Week High
  • ACCO $6.62
  • VERV $19.34
  • Technical
  • Relative Strength Index (RSI)
  • ACCO 41.81
  • VERV 53.75
  • Support Level
  • ACCO $4.93
  • VERV $5.32
  • Resistance Level
  • ACCO $5.31
  • VERV $6.87
  • Average True Range (ATR)
  • ACCO 0.15
  • VERV 0.52
  • MACD
  • ACCO 0.02
  • VERV -0.00
  • Stochastic Oscillator
  • ACCO 57.45
  • VERV 56.74

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. It offers its products under the AT-A-GLANCE, Five Star, GBC, Hilroy, Kensington, Quartet, Leitz, NOBO and other brands. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands North America segment.

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: